ISO/IEC 17025 accredited analytical method validation, forced degradation stress studies, and ultra-trace nitrosamine (NDSRI) detection.
Robust, stability-indicating analytical methods are foundational to modern pharmaceutical drug substance and drug product filings. Cleanchem Laboratories provides ISO/IEC 17025 and 21 CFR Part 11 compliant analytical method development, validation, and tech transfer services.
Our analytical team develops stability-indicating assays, dissolution testing protocols, and ultra-sensitive LC-MS/MS nitrosamine methods tailored to meet rigorous ICH Q2(R1) validation guidelines covering specificity, linearity, precision, accuracy, LOD/LOQ, and robustness.
Our analytical team develops stability-indicating assays, dissolution testing protocols, and ultra-sensitive LC-MS/MS nitrosamine methods tailored to meet rigorous ICH Q2(R1) validation guidelines covering specificity, linearity, precision, accuracy, LOD/LOQ, and robustness.
Specialized expertise engineered to resolve complex chemical challenges across target molecules:
Complete validation testing covering Specificity, Precision, Repeatability, Intermediate Precision, Accuracy, Range, and Solution Stability.
High-sensitivity LC-MS/MS and GC-MS/MS protocols quantifying genotoxic nitrosamines down to sub-ppm levels in line with FDA and EMA guidance.
Comprehensive stress testing under thermal, humidity, acid hydrolysis, base hydrolysis, oxidative (peroxide), and photolytic ICH Q1B conditions.
Comparative in vitro release profiles across pH 1.2, 4.5, 6.8, and bio-relevant media with statistical f1 (difference) and f2 (similarity) evaluation.
Transparent, milestone-governed stage gate execution keeping your research program strictly on schedule:
Evaluating chromatographic columns, mobile phases, and gradient profiles to ensure baseline separation between API and all known impurities.
Stress-testing the drug substance, demonstrating spectral homogeneity and mass balance using PDA and Q-TOF mass detectors.
Executing 6-analyst/multi-day validation runs verifying Linearity (r > 0.999), Accuracy (Recovery 98-102%), Repeatability, and Robustness.
Compilation of audit-proof validation dossier, raw data integration, electronic signatures, and method transfer SOP to sponsor laboratory.
Our Navi Mumbai and Mahad testing facilities are equipped with qualified, 21 CFR Part 11 compliant hardware:
| Instrument Platform | Technical Specifications | Primary Application |
|---|---|---|
| Agilent 1290 Infinity II UHPLC with DAD | Operating pressures up to 1300 bar, sub-2 micron columns | High-throughput stability-indicating method testing |
| AB Sciex Triple Quad 6500+ LC-MS/MS | Sub-picogram sensitivity, MRM mode | Ultra-trace NDSRI nitrosamine quantification |
| Agilent 7890B GC with Headspace Sampler | FID & MS detectors, 7697A Headspace | ICH Q3C Class 1, 2, 3 residual solvents testing |
| Electrolab 14-Vessel Dissolution Tester | USP Apparatus 1 (Baskets) & 2 (Paddles) | Multimedia comparative dissolution profile testing |
Every project concludes with a complete regulatory package ready for instant DMF/ANDA regulatory submission:
Cleanchem Laboratories successfully participates in Pharmaconex 2026 at the Egypt International Exhibition Center, engaging with pharmaceutical professionals from Egypt and across the region.